Skip to main content
Figure 3 | BMC Anesthesiology

Figure 3

From: Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial

Figure 3

Severity of pain over 48 postoperative hours in the female patients who underwent laparoscopic gynaecologic surgery, graded using a 10-point visual analogue scale (VAS). The data are expressed as mean ± standard error values of the mean. Group P was given 0.075 mg of palonosetron intravenously, whereas group A was given 40 mg of oral aprepitant.

Back to article page